FDA is optimistic that an increase in “no objection” responses to new dietary ingredient notifications signals a positive trend, but has a more critical view of the industry's clarity about when the notifications are required and information they should contain.
The number of “acknowledgement with no objection” letters FDA has sent for NDI notifications has increased over the past two years, said Cara Welch, senior advisor in the Office of Dietary
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?